Point72 Asia (Singapore) Pte. Ltd. Care Dx, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Care Dx, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 7,463 shares of CDNA stock, worth $165,305. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,463
Previous 10,264
27.29%
Holding current value
$165,305
Previous $320 Million
50.15%
% of portfolio
0.04%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding CDNA
# of Institutions
216Shares Held
53.3MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$117 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$108 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$58.9 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$53.4 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$48.9 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.18B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...